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Abstract. This research evaluated the lipid profile of type 2 diabetics in Almajmaah, Saudi 
Arabia. There is scarcity of literature about the assessment of lipid profile of type 2 diabetics in 
Saudi Arabia with very few studies addressing this issue. The data was collected from 350 
diabetic patients visiting the primary healthcare centres in Almajmaah, Saudi Arabia. The 
questionnaire comprised of socio-demographic and clinical data information. Systematic 
random sampling technique was used to collect the data from available sample frame of type 2 
diabetics. The median age of the patients was 45 (40 – 51) years. Majority of the patients were 
males as compared to females (57.7% vs 42.3%).  A significant dyslipidaemia was observed in 
diabetics. Patients had significantly high LDL, and TG level (p < 0.001) respectively. HDL-C 
of males was significantly high, whereas, for females, it was at borderline (p < 0.001) 
respectively. However, TC was not statistically significant (p = 0.405). The prime focus when 
treating diabetics is to introduce preventive and therapeutic lifestyle changes measures into a 
comprehensive treatment programme. The treating doctor must keep an eye on the lipid profile 
of diabetics that can be useful for the patients to reduce the morbidity from macrovascular 
complications. 
1.  Introduction 
Dyslipidaemia means the presence of high amount of fats and lipids in the blood. Diabetic dyslipidaemia 
refers to high Total Cholesterol (TC) or Triglyceride (TG) levels, low High-Density Lipoprotein-
Cholesterol (HDL-C) and increased level of Low-Density Lipoprotein-Cholesterol (LDL-C). 
Dyslipidaemia can be a major cause of Cardiovascular Disease (CVD) and stroke which is a 
macrovascular complication of Type 2 Diabetes Mellitus (T2DM) [1,2]. Several dietary interventional 
studies recommended nutrition therapy and lifestyle changes as the initial treatment for dyslipidaemia 
[3,4]. Consuming diet mainly composed of fruits, vegetables, olive oil and fish, but limiting the intake 
of diet like meat, fats and refined carbohydrates have shown to be beneficial for diabetics with 
dyslipidaemia. Previous international literature also reported that elevated TC, LDL-C, TG and low 
level of HDL-C are clear risk factors for Coronary Artery Disease (CAD) [5-7]. Diabetic patients have 
a high risk of developing CVD for which dyslipidaemia is a sole imperative risk factor. The result from 
clinical trials suggested treating dyslipidaemia in order to prevent macrovascular complications of 
Diabetes Mellitus (DM) [8]. A study compared the effects of high–monounsaturated fatty acid and high-
carbohydrate diets on body weight and glycaemic control in type 2 diabetics. Results showed a 
significant beneficial effect on body weight, body composition, cardiovascular risk factors, and 
glycaemic control [9]. In Kingdom of Saudi Arabia (KSA), there is a scarcity of literature related to 
diabetic dyslipidaemia and CAD with only a few studies addressing this issue [10]. Dyslipidaemia in 
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KSA is emerging as a serious health problem due to the economic shift and sedentary lifestyle [11]. A 
study conducted on dyslipidaemia among Saudi adults reported that prevalence of dyslipidaemia in 
KSA is increasing at a rapid pace which prophecies that CAD will be a major health problem in the 
coming years [12]. Adopting a healthy lifestyle including dietary modification, exercise, and regular 
health monitoring can lessen the risk of cardio-metabolic troubles in type 2 diabetics. 
2.  Methodology 
The data was collected from 350 diabetic patients visiting the primary healthcare centres in Almajmaah, 
Saudi Arabia. The questionnaire comprised of socio-demographic and clinical data information. Blood 
sample was taken from the patients after informed consent to test the current level of lipid profile. 
Systematic random sampling technique was used to collect the data from available sample frame of 
type 2 diabetics. The sample size was calculated using the level of precision formula. The collected data 
was entered and analysed using IBM SPSS Statistics for Windows, version 23 (IBM Corp., Armonk, 
N.Y., USA). Normality of quantitative variables was checked through One-Sample Kolmogorov 
Smirnov (K-S) test. Descriptive statistics are reported in order to describe frequencies, percentages and 
medians and quartiles (25th – 75th) for non-normally distributed quantitative variables. Quantitative lipid 
profile values were categorized. One-sample chi-square test was used to determine whether the 
distribution in a single categorical variable follows a known or hypothesised distribution.   
 
3. Results 
3.1.  Socio-demographic characteristics of patients 
The median age of the patients was 45 (40 – 51) years. Majority of the patients were males as compared 
to females (57.7% vs 42.3%). Major chunk of the patients was married (n = 322; 92%), a few numbers 
of patients 3.1% were single / divorced / separated and only 1.7% patients were widow. Almost one 
quarter (32.9%) of patients received education till primary followed by secondary / middle (n = 85; 
24.3%), illiterates were (n = 69; 19.7%), graduates were (n = 51; 14.6%) and a few number of patients 
had postgraduate degrees (n = 30; 8.6%). Most of the patients were doing own business (n = 163; 
46.6%), around 30% were housewives, one-fourth patients were government employees (n = 74; 
21.1%), and only 3.1% patients were unemployed. Majority of the patients (n = 113; 32.2%) were not 
earning (housewives + unemployed). Those who were earning, bulk of them (n = 65; 18.6%) had 
monthly income between 3000 – 5000 SAR, followed by 17.4% who had monthly income between 
5,001 – 10,000 SAR, patients earning < 3000 SAR were (16%), 11.4% patients were earning between 
10,001 – 15,000 SAR and only 4.3% had monthly income > 15,000 SAR. Almost two-quarter of the 
patients were performing a low physical activity (n = 222; 63.4%), moderate physical activity was 
observed in one-quarter of patients (33.4%), and only 3.1% were performing intense physical activity. 
The results are presented in Table 1. 
 
Table 1. Sociodemographic Characteristics of Patients (n = 350). 
 n (%)  n (%) 
Gender 
Male 
Female 
 
202 (57.7) 
148 (42.3) 
Occupation 
Unemployed 
Government Employee 
Own business 
Housewives 
 
11 (3.1) 
74 (21.1) 
163 (46.6) 
102 (29.1) 
Marital Status 
Married 
Single 
Widow 
Divorced / Separate 
 
322 (92.0) 
11 (3.1) 
06 (1.7) 
11 (3.1) 
Monthly Income (SAR) 
< 3000 
3000 – 5000 
5001 – 10,000 
10,001 – 15,000 
>15,000 
Not Earning 
 
56 (16.0) 
65 (18.6) 
61 (17.4) 
40 (11.4) 
15 (4.3) 
113 (32.2) 
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Education Status 
Illiterate 
Primary 
Secondary / Middle 
Graduate 
Postgraduate 
 
69 (19.7) 
115 (32.9) 
85 (24.3) 
51 (14.6) 
30 (8.6) 
Physical Activity 
Low physical activity 
Moderate physical activity 
Intense physical activity 
 
222 (63.4) 
117 (33.4) 
11 (3.1) 
 
3.2.  Lipid Profile Descriptive Analysis 
The median LDL-C of patients was 148.65 (119.69 – 173.43) mg/dl. The minimum and maximum 
values were 77.2 mg/dl and 350.88 mg/dl respectively. Majority of the patients’ LDL-C was abnormal 
(n = 156; 44.57%) followed by borderline (n = 75; 21.4%), near optimum (n = 65; 18.6) and optimum 
(n = 54; 15.4%). Median HDL-C for males was 39.77 (31.66 – 46.49), whereas, for females the median 
HDL-C was 52.22 (36.87 – 56.98) mg/dl. A significant association was observed between HDL-C levels 
of males and females (p < 0.001). More than 50% of the male patients had a high HDL-C level, followed 
by borderline (n = 63; 31.2%) and only 17.3% had an optimum HDL-C level. Whereas, HDL-C level 
of the bulk of female patients was at borderline (n = 67; 45.3%), followed by high (n = 54; 36.5%) and 
only 18.2% had an optimum HDL-C level. Median TG level of patients was 194.69 (157.52 – 246.64) 
mg/dl. Minimum TG level was 76.91 mg/dl, and the maximum was 614.66 mg/dl. Highest number of 
patients had abnormal TG level (n = 170; 48.5%), followed by borderline (n = 102; 29.1) and normal 
(n = 78; 22.3%). The Median TC level of patients was 220.07 (184 – 284.25) mg/dl. The minimum 
level of TC was 136 mg/dl, and the maximum was 370 mg/dl. More than one-quarter of patients had 
high TC level followed by normal (n = 114; 32.6), and around 31% patients had borderline TC level. 
 
Table 2. Lipid Profile of Patients (n = 350). 
Lipid Profile Result Cut-off                 n (%) 
LDL-C 
Optimum 
Near optimum 
Borderline 
High 
Very high 
<100 mg/dl 
100 – 130 mg/dl 
131 – 159 mg/dl 
160 – 190 mg/dl 
>190 mg/dl 
54 (15.4) 
65 (18.6) 
75 (21.4) 
101 (28.9) 
55 (15.7) 
HDL-C 
 
Male 
 
 
 
Female 
 
Optimum 
Borderline 
High  
 
Optimum 
Borderline 
High 
 
>60 mg/dl 
40 – 59 mg/dl 
<40 mg/dl 
 
>60 mg/dl 
50 – 59 mg/dl 
<50 mg/dl 
 
35 (17.3) 
63 (31.2) 
104 (51.5) 
 
27 (18.2) 
67 (45.3) 
54 (36.5) 
TG 
 
Normal 
Borderline 
High 
Very high 
 
<150 mg/dl 
150 – 199 mg/dl 
200 – 499 mg/dl 
>500 mg/dl 
78 (22.3) 
 
102 (29.1) 
144 (41.1) 
26 (7.4) 
TC 
 
Normal 
Borderline 
High 
 
<200 mg/dl 
200 – 239 mg/dl 
>240 mg/dl 
 
114 (32.6) 
108 (30.9) 
128 6.6) 
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3.3. Lipid Profile Inferential Analysis 
Results of one-sample chi-square test presented in Table 3 showed the presence of significant 
dyslipidaemia in diabetics. Patients had significantly high LDL, and TG level (p < 0.001) respectively. 
HDL-C of males was significantly high, whereas, for females, it was at borderline (p < 0.001) 
respectively. However, TC was not statistically significant (p = 0.405). 
 
Table 3. Significance of Lipid Profile (n = 350). 
Lipid Profile                   Result         n (%) χ2 (df) p – value 
LDL-C 
Optimum 
Near optimum 
Borderline 
High 
Very high 
54 (15.4) 
65 (18.6) 
75 (21.4) 
101 (28.9) 
55 (15.7) 
21.31 (4) < 0.001 
HDL-C 
 
Male 
 
 
 
Female 
 
Optimum 
Borderline 
High  
 
Optimum 
Borderline 
High 
 
35 (17.3) 
63 (31.2) 
104 (51.5) 
 
27 (18.2) 
67 (45.3) 
54 (36.5) 
 
 
35.77 (2) 
 
 
 
16.87 (2) 
 
 
< 0.001 
 
 
 
< 0.001 
 
TG 
Normal 
 
Borderline 
High 
Very high 
78 (22.3) 
 
102 (29.1) 
144 (41.1) 
26 (7.4) 
83.14 (3) < 0.001 
TC 
 
Normal 
Borderline 
High 
 
114 (32.6) 
108 (30.9) 
128 (36.6) 
1.80 (2) 0.405 
 
4. Discussion 
Our study results are consistent with a recently published study [13] who also reported presence of 
significant dyslipidaemia among type 2 diabetics, however, levels of LDL-C (64.4%), HDL-C (64%) 
and TG (53.77%) were reported to be higher in comparison to our study. TC (30.3%) was the only 
profile marker which was elevated more in our study patients. Results of another study [14] reported 
that despite using lipid-lowering drugs, most type 2 diabetics have dyslipidaemia. LDL-C was high in 
almost (80%) of the patients. In comparison to our study, LDL-C was high is (44.6%) of the patients. 
Results of our study are also consistent with a study [11] which revealed the same pattern of presence 
of significant dyslipidaemia among type 2 diabetics i.e., elevated TC, TG, LDL-C and low levels of 
HDL-C. Our study result is consistent with another study [15] who also reported the presence of 
significant dyslipidaemia in Saudi adults. A study reported extremely high dyslipidaemia among Saudi 
adults [16], results showed that low HDL-C was the most prevalent (88.6%) followed by 
hypertriglyceridemia (34%). Comparing this study results showed that in our study TG had the highest 
prevalence follow by LDL-C, TC, and HDL-C. According to another study [17], high frequency of 
dyslipidaemia was found in Saudi type 2 diabetics, TC (56.6%), TG (23.6%), LDL-C (77.1%) and 
HDL-C (48.9%). Findings of our research also revealed the presence of significant dyslipidaemia in 
type 2 diabetics, however, in our study, TG had the highest prevalence followed by LDL-C, TC, and 
HDL-C. 
In our study, more than 50% of the patients had hypercholesterolemia, and one-fourth of 
patients had hypertriglyceridemia, these high levels can also be the predictors for development of CAD 
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in our study patients. Our study results are congruent to a study conducted in 2013 [18] where female 
diabetics had significantly lower HDL-C level than male diabetics (p < 0.001). Many other published 
studies conducted on type 2 diabetics’ associated lifestyle with dyslipidaemia [19-21].  The cornerstone 
of keeping lipid profile in acceptable ranges is to make changes in lifestyle which can be best achieved 
using patient empowerment approach. The approach of patient empowerment makes patients choose 
purposeful and realistic goals like that of weight loss, nutrition and other physical activities [22]. Our 
study results demonstrated that urgent need is required to develop primary prevention strategies for 
treatment of dyslipidaemia among type 2 diabetes in KSA. Diet and exercise are the most important 
factors to focus on when talking about lifestyle changes. The healthcare provider should empower the 
patients by describing benefits of healthy eating and weight loss and their positive effect on lipid profile. 
Weight loss alone has also been proved to decrease TC, TG, and LDL-C and increase HDL-C levels.  
             
5. Conclusion 
The prime focus when treating diabetics is to introduce preventive and therapeutic lifestyle changes 
measures into a comprehensive treatment program. The treating doctor must keep an eye on the lipid 
profile of diabetics that can be useful for the patients to reduce the morbidity from cardiovascular 
complications. The healthcare provider should empower the patients by describing benefits of healthy 
eating and weight loss and their positive effect on lipid profile. 
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